We are international
Donate
• advocacy   TEXT SIZE   
advocate of the month

Advocacy Update - February 15, 2011
The text of the House fiscal year 2011 Continuing Resolution was released last week and it provides cuts to the cancer research and control programs at the National Institutes of Health, Centers for Disease Control and Prevention, and the Food and Drug Administration.
02.15.11

February 15, 2011

Latest House FY 2011 CR Proposes Funding Cuts to Cancer Programs

The text of the House fiscal year (FY) 2011 Continuing Resolution (CR) was released last week and it provides cuts to the cancer research and control programs at the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA).   The NIH budget would be cut by $1.6 billion which is 4% below the FY 2010 funding level.  Additionally, the CDC will see a decrease of 21% or $1.3 billion below FY 2010.  The CR does not contain a specific breakdown of the funding cuts to the CDC cancer prevention and control programs including the Geraldine Ferraro Blood Cancer Program, but it is a safe assumption that they will see funding decreases in FY 2011.  The FDA budget is cut by $241 million under the CR.  The House will debate and vote on the CR this week. 

President Releases FY 2012 Budget

The President released his FY 2012 budget on February14.  He proposed $79.9 billion in discretionary spending for the Department of Health and Human Services (HHS), an increase of $95 million from FY 2011.  Within HHS, the budget request for the NIH for FY 2012 is $31.987 billion; this is an increase of $745 million, or 2.4%, over FY 2010 levels. The budget request for the National Cancer Institute is $5.196 billion, an increase of $95 million over FY 2010.  The FY 2012 budget request includes $100 million for the Cures Acceleration Network.

The CDC budget request shows an increase of $371 million over FY 2010 levels.  However, there would be a substantial change in the chronic disease program where the Geraldine Ferraro Blood Cancer Program is currently housed.  There would become a single chronic disease block grant to the states, which would result in the elimination of all disease-specific programs that have been part of the chronic disease program at CDC.  The budget request for FDA for FY 2012 represents an increase of approximately $1 billion over FY 2010 levels. 

 

For more information about the legislation listed above or any other IMF advocacy initiative, contact IMF’s Director of Government Relations, Christine Murphy at cmurphy@myeloma.org or 703-738-1498.


 related articles